Safety of efavirenz in the first trimester of pregnancy
Nathan Ford(World Health Organization), Françoise Renaud(Apple (Israel)), Zara Shubber(World Bank Group), Isabelle Andrieux‐Meyer(Drugs for Neglected Diseases Initiative), Alexandra Calmy(University Hospital of Geneva), Marco Vitória(World Health Organization), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Nathan Shaffer(World Health Organization)
Cited by 274
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697